Belgian Real Estate Stock News

Groupe Bruxelles Lambert (ENXTBR:GBLB) drew investor attention after reporting half year 2026 earnings, with sales of €3,359.3 million and net income of €53.5 million, alongside higher basic and diluted earnings per share. See our latest analysis for Groupe Bruxelles Lambert. Following the half year 2026 earnings release, Groupe Bruxelles Lambert’s share price at €79.0 has seen modest short term gains, while the 1 year total shareholder return of 13.93% points to steadier longer term...

Viohalco (ENXTBR:VIO) drew investor attention after reporting half year 2026 earnings on 29 July, with sales of €2,197.59m and net income of €123.63m compared to the prior year period. See our latest analysis for Viohalco. Viohalco’s half year 2026 update has arrived alongside strong price momentum, with the latest share price at €18.3, a year to date share price return of 51.49% and a 1 year total shareholder return of 205.25%. However, the 30 day share price return has slipped 4.19%, which...

Syensqo (ENXTBR:SYENS) reported mixed Q2 2026 results that quickly put the stock on investor watchlists. Quarterly sales reached €1,611 million while net income declined, even as first half earnings from continuing operations improved. See our latest analysis for Syensqo. Since the Q2 2026 earnings call on 30 July, Syensqo’s share price has pushed higher, with a 19.43% 1 month share price return and a 36.38% 3 month share price return contributing to a 10.54% 1 year total shareholder return...

UCB (ENXTBR:UCB) is back in focus after first half 2026 results showed sales of €4.09b and net income of €1.11b, with management also raising full year guidance on the back of BIMZELX momentum. See our latest analysis for UCB. Despite the strong first half update, UCB’s 1 month share price return is down 13.57% and the 7 day share price return is down 9.39%. However, the 1 year total shareholder return is 21.12% and the 3 year total shareholder return is very large, which points to longer...

Umicore shares have climbed 25.7% over the past three months and closed at €21.60 on 31 July, which tells you sentiment has already swung sharply higher before these numbers hit. The question now is whether that optimism really matches what just landed in the half year report. The headline is clear. Umicore delivered a powerful profit and cash flow surge, with adjusted earnings before interest, tax, depreciation and amortisation at €577m and free operating cash flow at €295m. The stock is...

Warehouses De Pauw trades like a quiet income REIT at €22.32, and the latest numbers put the balance sheet and valuation debate back in the spotlight. The stock sits at a discount to one widely used fair value model while carrying a higher P/E than many direct peers. At the same time, earnings over the past year include a sizeable one off gain and profit margins have compressed, which matters for a sector built on steady cash flows. For investors, the key issue this quarter is the tension...

Proximus PLC has released its half-year results for the period ended June 30, 2026, reporting sales of €3,030 million, revenue of €3,125 million, and net income of €278 million, all lower than the same period a year earlier, with basic and diluted EPS from continuing operations easing to €0.86 from €0.97. The simultaneous declines in revenue, net income and earnings per share suggest that both top-line and profitability pressures weighed on Proximus’s performance over the past six...

Anheuser-Busch InBev stock closed at €75.2 after a run that left short term holders sitting on double digit gains over the past quarter. The real story sits in the earnings print. Q2 revenue reached $16,660m and underlying earnings per share stepped up sharply, helping lift trailing net profit margins to 14.9% from 12.2% a year earlier. For a brewer that still carries a high level of debt, that margin improvement matters more than today’s price flicker. It reshapes how you weigh the current...

Syensqo stock came into this earnings print on a strong run, with the share price up about 36% over the past three months, and expectations already running high for a turnaround in specialty materials. The headline today is margin pressure, not a revenue story. Sales in the quarter reached €1,554m while basic earnings per share landed at €0.24, and underlying EBITDA of €311m translated into a roughly 20% margin. For a company still loss making over the last twelve months, that profit squeeze...

Ontex Group stock closed at €2.315 after a choppy few months, with the share price down roughly 20% over ninety days. The market has been wrestling with a simple question: is this just a cheap, troubled hygiene products producer or a deeply discounted turnaround story? The latest half year results put that tension in sharp focus. Adjusted EBITDA for H1 2026 landed at €78m, with margins still under pressure and a large €144m impairment charge tied to a sweeping transformation review. The rest...

NV Bekaert walked into this earnings print with a stock that had drifted, down about 5% over the past week and roughly flat over a month, as investors weighed slow revenue growth against a higher than peer P/E and a generous but thinly covered dividend. The headline today is not the top line. It is the profitability squeeze. Net profit margin over the last 12 months sits at 2.2% compared with 4.5% a year earlier. That gap, amplified by a large one off loss, is what is really driving sentiment...

Solvay went into this earnings print as a heavily discounted stock, with the share price at €26.56 and flagged as trading far below an estimated fair value. The market has treated it as a structurally challenged chemicals group with high debt and a stretched dividend, so every quarter now serves as a credibility check on the turnaround story. The headline this time is profit quality. Quarterly basic earnings per share moved to €0.60 on net income of €63m, yet trailing twelve month figures...

Fagron stock closed at €23.20 on Friday, rounding off a month where the share price drifted about 3% lower despite a fresh set of half year numbers. On a short view the market looks lukewarm. On a longer view the headline is different. Earnings per share over the trailing twelve months sit at €1.25 and the P/E multiple of 18.5x still sits below healthcare peers. The key tension this season is not the income statement. It is the balance sheet. High debt remains the central issue that long term...

UCB walked into this earnings print with a stock that had lost ground, down about 9% over the past week and 14% over the past month, even as trailing earnings and valuation looked supportive. The headline today is earnings power. Basic earnings per share for the first half of 2026 came in at €5.83 and trailing twelve month earnings reached €11.52 per share, underpinned by €2.19b of net income from continuing operations. The market had already priced in worry. The earnings show a business that...

Azelis Group went into these results with a stock that had quietly climbed about 20% over the past month, yet still trades near €11. Today the chemicals distributor put the focus squarely on profitability. Net income for the first half of 2026 came in at €85.2m on revenue of €2,165.8m. This keeps the spotlight on margins for a business that recently ran a trailing net margin of 2.7%. For you as an investor, the tension is clear. The share price looks muted against a business that is still...

Elia Group went into this earnings season with a premium story and a premium price. The stock is down about 11% over three months and another 10% over the past month, even after closing at €125.8 on 30 July. Yet the grid operator just posted a strong H1 2026, with net income of €348.6m and adjusted profit around €411m, while reaffirming full year profit guidance and edging the weakest segment toward breakeven. Love Elia Group’s resilient earnings but concerned about paying a premium after the...

Viohalco went into this earnings print with a mixed setup. The stock had climbed roughly 17% over three months, yet slipped about 10% over the last month as investors questioned how much of the metals cycle was already priced in. The headline from these Q2 numbers is clear: profitability held up. Net income from continuing operations over the trailing twelve months came in at €288.1m, on €7.6b of revenue, and the P/E of 15.4x now sits between Belgian peers and the wider European Metals &...

Solvay reported a quarter with a 20% EBITDA decline, confirmed its full-year 2026 guidance, and in 2026 restarted its peroxide plant in Saudi Arabia while committing further capital to expand rare earth separation capacity at its La Rochelle site. A key differentiator is Solvay’s position as the only company outside China able to separate all 17 rare earth elements, which could prove important for customers seeking diversified supply chains. Next, we’ll examine how Solvay’s rare earth...

As European markets navigate the complexities of robust corporate earnings, heightened geopolitical tensions, and fluctuating oil prices, investors are keenly observing opportunities that may arise from these conditions. With the pan-European STOXX Europe 600 Index showing modest gains amid these developments, identifying undervalued stocks becomes crucial for those looking to capitalize on potential market inefficiencies. In this context, a good stock might be one that demonstrates strong...

Idaho investment puts Anheuser-Busch InBev ENXTBR:ABI supply chain in focus Anheuser-Busch InBev ENXTBR:ABI is putting fresh attention on its barley supply chain after announcing a $4 million investment in Idaho Falls operations and a $50,000 grant to the University of Idaho for barley research. See our latest analysis for Anheuser-Busch InBev. At a share price of €71.64, Anheuser-Busch InBev has a 90 day share price return of 12.22% and a year to date share price return of 31.69%. The 5 year...

As the pan-European STOXX Europe 600 Index edges higher amidst robust corporate earnings and geopolitical tensions, investors are closely monitoring the implications of rising oil prices and potential interest rate changes by the European Central Bank. In this dynamic environment, dividend stocks can offer a stable income stream, making them an attractive option for those looking to navigate market fluctuations while benefiting from regular payouts.

argenx (ENXTBR:ARGX) is back in focus after reporting half year 2026 earnings, with revenue of US$2.854b and net income of US$838m, supported by VYVGART and its expanded generalized myasthenia gravis reach. See our latest analysis for argenx. argenx's recent half year earnings and VYVGART label expansion have coincided with building momentum, with a 20.74% 90 day share price return and a 59.60% 1 year total shareholder return from a €804.4 share price today. If you are interested in other...

argenx (ENXTBR:ARGX) has put up another busy quarter, with Q2 2026 revenue at roughly US$1.5 billion and basic EPS of US$7.57, while trailing twelve month revenue sits at about US$5.3 billion and EPS at US$27.72, supported by net income of US$1.7 billion over that period. Over recent quarters the company has seen revenue move from US$967.63 million in Q2 2025 to US$1.54 billion in Q2 2026, alongside basic EPS stepping from US$4.02 to US$7.57. This sets the stage for investors to focus on how...

Econocom Group (ENXTBR:ECONB) has reported its H1 2026 results with revenue trends that have recently ranged from about €1.42 billion in H1 2025 to €1.50 billion in H2 2025, alongside basic EPS moving from €0.114 to €0.205 over the same period. This sets the stage for investors to focus on how those headline lines translate into underlying profitability. The company has seen total revenue move from €1.47 billion in H2 2024 to €1.50 billion in H2 2025, while trailing twelve month EPS values of...